Capacitation of bovine spermatozoa by lysophospholipids and trypsin.
Bovine spermatozoa were incubated in vitro with lysophosphatidylserine (LPS), lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), lysophosphatidylinositol (LPI), or trypsin. Capacitation of sperm was evaluated by penetration of the zonae pellucidae of dead bovine oocytes. Capacitation times could be shortened to 3 h or less by treatment of spermatozoa with each of these lysophospholipids (LPLs) (P less than .05). The maximum oocyte penetration percentages for individual LPLs were 40% for 10 microM LPS. 24% for 160 microM LPC, 31% for 320 microM LPE, and 19% for 320 microM LPI. Capacitation also was facilitated (P less than .01) by trypsin treatment of spermatozoa. Spermatozoa treated with 250 or 2,500 units/ml of trypsin penetrated more oocytes (17 and 18%) than spermatozoa treated with 0 or 25 units/ml of trypsin (0 and 3%). Spermatozoa treated with increasing concentrations of LPL showed a decrease in both the percentage of intact acrosomes and of progressively motile spermatozoa. Increasing levels of trypsin in the incubation medium also led to a decrease (P less than .05) in the percentages of intact acrosomes and a decrease (P less than .01) in the percentages of progressively motile spermatozoa. Percentages of live, ovulated oocytes fertilized by spermatozoa incubated for 1 h in LPS (86%, 6/7) were not different from those incubated for 24 h in control medium (71%, 5/7). Percentages of oocytes fertilized with both of these capacitation treatments were higher (P less than .05) than for oocytes exposed or killed or uncapacitated sperm. Rapid induction of capacitation and the acrosome reaction can be accomplished by exogenous treatment of bovine sperm with lysophospholipids or trypsin.
Wheeler
M B
MB
Animal Reproduction Laboratory, Colorado State University, Fort Collins.
Seidel
G E
GE
D000818:Animals; D002417:Cattle; D004305:Dose-Response Relationship, Drug; D004542:Ejaculation; D005260:Female; D005307:Fertilization in Vitro; D008246:Lysophospholipids / Q000494:pharmacology*; D008297:Male; D009865:Oocytes / Q000187:drug effects / Q000502:physiology; D013075:Sperm Capacitation / Q000187:drug effects*; D013081:Sperm Motility / Q000187:drug effects*; D013084:Sperm-Ovum Interactions / Q000187:drug effects; D013094:Spermatozoa / Q000187:drug effects / Q000502:physiology; D014357:Trypsin / Q000494:pharmacology*
D008246:Lysophospholipids; D014357:Trypsin